Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

The AMARANTH and DAYBREAK-ALZ randomized clinical trials assess whether lanabecestat slows the progression of Alzheimer disease compared with placebo in patients with early Alzheimer disease or mild Alzheimer disease dementia.
Source: JAMA Neurology - Category: Neurology Source Type: research